US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Inhibrx Biosciences

109.35

+4.624.41%

Post-market: 109.350.00000.00%19:30 EDT

Volume:483.38K

Turnover:52.51M

Market Cap:1.60B

PE:-12.32

High:110.41

Open:106.45

Low:105.04

Close:104.73

52wk High:155.29

52wk Low:26.20

Shares:14.67M

Float Shares:8.64M

Volume Ratio:1.88

T/O Rate:5.60%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-8.8768

EPS(LYR):-9.0434

ROE:-1773.60%

ROA:-43.61%

PB:-30.28

PE(LYR):-12.09

Loading ...

Overview Company News Filings

Top Insider Makes Bold Move at Inhibrx Biosciences

Inhibrx Biosciences Director Jon Faiz Kayyem Acquires $500,000 in Common Shares

Inhibrx Biosciences Director Kimberly Manhard Sells Common Shares Worth $115,467.50

Inhibrx Biosciences reports strong Phase 2 INBRX-106 data

Inhibrx CEO Mark Lappe Reports Acquisition of 25,000 Common Shares Worth $2.59 Million

Inhibrx Biosciences Shares Fall 22% After Co Releases Data from Mid-Stage Study of Its Experimental Combination Cancer Drug

THOMSON REUTERS

Analysts Offer Insights on NA Companies: First Horizon (FHN) and Inhibrx Biosciences Inc (INBX)

Inhibrx Biosciences Says Cancer Combination Therapy Shows Improved Response in Phase 2 Study

MT Newswires Live

Inhibrx Biosciences Reports Positive Study Results for Squamous Cell Carcinoma Treatment

Inhibrx Says Phase 2 Trial Shows INBRX-106 Plus Pembrolizumab Lifts Response Rate to 48.3% in HNSCC

Inhibrx Biosciences: Currently Conducting Phase 1/2 Study of Inbrx-106 in Perioperative Setting of Nsclc, with Initial Results Targeted by Mid-2027

THOMSON REUTERS

Inhibrx Biosciences Inc: Evaluating Potential of Inbrx-106 in Other Highly Immunogenic Tumor Types

THOMSON REUTERS

Inhibrx Biosciences - to Expand Phase 2 Study by 50 Hpv+ Patients

THOMSON REUTERS

Inhibrx Biosciences - Inbrx-106 Plus Pembrolizumab Achieves 48.3% Corr and 72.4% Six-Month Pfs Rate

THOMSON REUTERS

Inhibrx Biosciences Inc: Also Plans to Explore Potential of Inbrx-106 in Combination with Therapeutic Cancer Vaccines

THOMSON REUTERS

Inhibrx's Inbrx-106 Nearly Doubles Response Rate and Achieves Interim Median Pfs of 9.6 Months in Phase 2 Hnscc Study

THOMSON REUTERS

NASDAQ Trade Halt Halt News Pending at 07:25 Am

Inhibrx Schedules Sept. 8 Webcast to Release Phase 2 INBRX-106 First-Line HNSCC Study Endpoint Results

Inhibrx Biosciences Price Target Announced at $245.00/Share by HC Wainwright & Co.

Inhibrx Biosciences, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $245

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/INBX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INBX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INBX\",,,,,undefined,":{"symbol":"INBX","market":"US","secType":"STK","nameCN":"Inhibrx Biosciences","latestPrice":109.35,"timestamp":1789761600000,"preClose":104.73,"halted":0,"volume":483377,"hourTrading":{"tag":"盘后","latestPrice":109.35,"preClose":109.35,"latestTime":"19:30 EDT","volume":44713,"amount":4889364.4626,"timestamp":1789774204503,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.04411343454597527,"floatShares":8638900,"shares":14671186,"eps":-8.876818,"marketStatus":"Market Closed","change":4.62,"latestTime":"09-18 16:00:00 EDT","open":106.45,"high":110.41,"low":105.04,"amount":52507409.094285,"amplitude":0.051275,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.876818,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":104.73,"preHourTrading":{"tag":"盘前","latestPrice":106.56,"preClose":104.73,"latestTime":"09:29 EDT","volume":2908,"amount":311778.54464,"timestamp":1789738199999,"change":1.83,"changeRate":0.017474,"amplitude":0.044964},"postHourTrading":{"tag":"盘后","latestPrice":109.35,"preClose":109.35,"latestTime":"19:30 EDT","volume":44713,"amount":4889364.4626,"timestamp":1789774204503,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.8832155986389179,"impliedVol":0.8558,"impliedVolPercentile":0.2271},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INBX\",,,,,undefined,":{"symbol":"INBX","floatShares":8638900,"roa":"-43.61%","roe":"-1773.60%","lyrEps":-9.043391,"volumeRatio":1.8832155986389179,"shares":14671186,"dividePrice":0,"high":110.41,"amplitude":0.051275,"preClose":104.73,"low":105.04,"week52Low":26.202,"pbRate":"-30.28","week52High":155.29,"institutionHeld":0,"latestPrice":109.35,"eps":-8.876818,"divideRate":0,"volume":483377,"delay":0,"ttmEps":-8.876818,"open":106.45,"prevYearClose":79,"prevWeekClose":109.27,"prevMonthClose":126.7,"prevQuarterClose":94.75,"fiveDayClose":109.27,"twentyDayClose":99.15,"sixtyDayClose":95.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INBX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"INBX","fiscalQuarterEnding":"2026/06","expectedEps":-2.5,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-2.34},{"market":"US","date":"2026-05-14","symbol":"INBX","fiscalQuarterEnding":"2026/03","expectedEps":-2.37,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-2.15},{"market":"US","date":"2026-03-19","symbol":"INBX","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"post","actualEps":-2.11},{"market":"US","date":"2025-11-14","symbol":"INBX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-2.28},{"market":"US","date":"2025-08-13","symbol":"INBX","fiscalQuarterEnding":"2025/06","expectedEps":-2.92,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-1.85}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INBX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INBX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1787630400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INBX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INBX","date":"2026-09-18","current":-12.318603,"percent":0.139592,"low":-22.314917,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"high":0.20643,"avg":-6.661132,"sd":5.098116,"marketCap":1541380531},"quantilePoints":[{"date":"2021-09-24","current":-17.829629,"twenty":-16.480889,"median":-12.612787,"eighty":-8.953333,"marketCap":1393296341},{"date":"2021-10-01","current":-15.730029,"twenty":-16.490733,"median":-12.663254,"eighty":-8.96336,"marketCap":1229223097},{"date":"2021-10-08","current":-12.97097,"twenty":-16.480889,"median":-12.827884,"eighty":-9.035825,"marketCap":1013616457},{"date":"2021-10-15","current":-19.255223,"twenty":-16.545624,"median":-12.97097,"eighty":-9.054369,"marketCap":1504699420},{"date":"2021-10-22","current":-18.493936,"twenty":-16.728002,"median":-13.052038,"eighty":-9.0546,"marketCap":1445208660},{"date":"2021-10-29","current":-19.487973,"twenty":-16.918658,"median":-13.192599,"eighty":-9.065511,"marketCap":1522887678},{"date":"2021-11-05","current":-21.694251,"twenty":-17.230296,"median":-13.217847,"eighty":-9.068239,"marketCap":1695297206},{"date":"2021-11-12","current":-20.979364,"twenty":-17.376546,"median":-13.248255,"eighty":-9.084018,"marketCap":1641173724},{"date":"2021-11-19","current":-21.018179,"twenty":-17.627693,"median":-13.306251,"eighty":-9.093008,"marketCap":1644210123},{"date":"2021-11-26","current":-18.59711,"twenty":-17.724892,"median":-13.36308,"eighty":-9.09439,"marketCap":1454814728},{"date":"2021-12-03","current":-17.903297,"twenty":-17.836807,"median":-13.397679,"eighty":-9.099442,"marketCap":1400539094},{"date":"2021-12-10","current":-19.009517,"twenty":-17.922319,"median":-13.461918,"eighty":-9.105715,"marketCap":1487076469},{"date":"2021-12-17","current":-21.411178,"twenty":-18.339089,"median":-13.523752,"eighty":-9.141289,"marketCap":1674953664},{"date":"2021-12-23","current":-21.576141,"twenty":-18.404686,"median":-13.538298,"eighty":-9.19146,"marketCap":1687858360},{"date":"2021-12-31","current":-21.187994,"twenty":-18.643832,"median":-13.635278,"eighty":-9.244088,"marketCap":1657494369},{"date":"2022-01-07","current":-16.535077,"twenty":-18.65535,"median":-13.71468,"eighty":-9.282247,"marketCap":1293506025},{"date":"2022-01-14","current":-15.273598,"twenty":-18.643832,"median":-13.796526,"eighty":-9.316764,"marketCap":1194823053},{"date":"2022-01-21","current":-13.614268,"twenty":-18.628162,"median":-13.763835,"eighty":-9.324228,"marketCap":1065016991},{"date":"2022-01-28","current":-11.940383,"twenty":-18.576475,"median":-13.688616,"eighty":-9.34366,"marketCap":934072279},{"date":"2022-02-04","current":-12.561419,"twenty":-18.478419,"median":-13.607802,"eighty":-9.350296,"marketCap":982654665},{"date":"2022-02-11","current":-11.285384,"twenty":-18.41052,"median":-13.552845,"eighty":-9.3572,"marketCap":882833044},{"date":"2022-02-18","current":-10.460571,"twenty":-18.383151,"median":-13.530363,"eighty":-9.371993,"marketCap":818309562},{"date":"2022-02-25","current":-10.741978,"twenty":-18.367013,"median":-13.519646,"eighty":-9.383827,"marketCap":840323456},{"date":"2022-03-04","current":-9.688638,"twenty":-18.346841,"median":-13.443599,"eighty":-9.410447,"marketCap":792220573},{"date":"2022-03-11","current":-10.270911,"twenty":-18.333921,"median":-13.396092,"eighty":-9.411627,"marketCap":839831858},{"date":"2022-03-18","current":-12.055911,"twenty":-18.155202,"median":-13.338179,"eighty":-9.438069,"marketCap":985787767},{"date":"2022-03-25","current":-10.30432,"twenty":-18.141037,"median":-13.280794,"eighty":-9.467655,"marketCap":842563653},{"date":"2022-04-01","current":-11.182502,"twenty":-18.091473,"median":-13.235825,"eighty":-9.492956,"marketCap":914370838},{"date":"2022-04-08","current":-10.084775,"twenty":-18.029445,"median":-13.217847,"eighty":-9.550229,"marketCap":824611857},{"date":"2022-04-14","current":-8.743823,"twenty":-17.966571,"median":-13.19269,"eighty":-9.432781,"marketCap":714964912},{"date":"2022-04-22","current":-7.813121,"twenty":-17.912808,"median":-13.077138,"eighty":-9.380868,"marketCap":638863297},{"date":"2022-04-29","current":-7.564934,"twenty":-17.890994,"median":-13.002219,"eighty":-9.337742,"marketCap":618569533},{"date":"2022-05-06","current":-7.426522,"twenty":-17.855642,"median":-12.966698,"eighty":-9.255063,"marketCap":607251857},{"date":"2022-05-13","current":-7.055067,"twenty":-17.833218,"median":-12.861335,"eighty":-9.106701,"marketCap":661292590},{"date":"2022-05-20","current":-5.626562,"twenty":-17.771363,"median":-12.813715,"eighty":-9.084018,"marketCap":527394503},{"date":"2022-05-27","current":-5.684868,"twenty":-17.745237,"median":-12.660732,"eighty":-9.054369,"marketCap":532859731},{"date":"2022-06-03","current":-4.801943,"twenty":-17.737028,"median":-12.627593,"eighty":-8.95124,"marketCap":450100564},{"date":"2022-06-10","current":-4.089773,"twenty":-17.730073,"median":-12.561419,"eighty":-8.884803,"marketCap":383346708},{"date":"2022-06-17","current":-3.781583,"twenty":-17.724892,"median":-12.459267,"eighty":-8.824644,"marketCap":354459074},{"date":"2022-06-24","current":-4.881073,"twenty":-17.720352,"median":-12.408239,"eighty":-8.7684,"marketCap":457517659},{"date":"2022-07-01","current":-4.822767,"twenty":-17.684176,"median":-12.274934,"eighty":-8.715717,"marketCap":452052431},{"date":"2022-07-08","current":-7.17168,"twenty":-17.633745,"median":-12.248836,"eighty":-8.692608,"marketCap":672223046},{"date":"2022-07-15","current":-7.196668,"twenty":-17.617007,"median":-12.144125,"eighty":-8.612608,"marketCap":674565287},{"date":"2022-07-22","current":-8.458584,"twenty":-17.576513,"median":-12.055911,"eighty":-8.581377,"marketCap":792848436},{"date":"2022-07-29","current":-7.221656,"twenty":-17.524355,"median":-11.894179,"eighty":-8.56331,"marketCap":676907527},{"date":"2022-08-05","current":-9.512263,"twenty":-17.400753,"median":-11.861399,"eighty":-8.555407,"marketCap":891612914},{"date":"2022-08-12","current":-8.625805,"twenty":-17.350322,"median":-11.769735,"eighty":-8.539628,"marketCap":955350999},{"date":"2022-08-19","current":-6.788501,"twenty":-17.27656,"median":-11.657921,"eighty":-8.520336,"marketCap":751860455},{"date":"2022-08-26","current":-6.933087,"twenty":-17.270113,"median":-11.575505,"eighty":-8.459312,"marketCap":767874106},{"date":"2022-09-02","current":-5.698815,"twenty":-17.254503,"median":-11.411593,"eighty":-8.433116,"marketCap":631172205},{"date":"2022-09-09","current":-5.543649,"twenty":-17.222227,"median":-11.316139,"eighty":-8.402544,"marketCap":613986823},{"date":"2022-09-16","current":-5.099311,"twenty":-17.176839,"median":-11.219387,"eighty":-8.38282,"marketCap":564774139},{"date":"2022-09-23","current":-5.205105,"twenty":-17.156666,"median":-11.106139,"eighty":-8.343685,"marketCap":576491445},{"date":"2022-09-30","current":-6.330057,"twenty":-16.959985,"median":-11.073112,"eighty":-8.269405,"marketCap":701085463},{"date":"2022-10-07","current":-10.755807,"twenty":-16.908326,"median":-11.043041,"eighty":-8.269405,"marketCap":1191259423},{"date":"2022-10-14","current":-10.526585,"twenty":-16.889381,"median":-10.983634,"eighty":-8.297841,"marketCap":1165871927},{"date":"2022-10-21","current":-10.932132,"twenty":-16.806498,"median":-10.958184,"eighty":-8.303923,"marketCap":1210788266},{"date":"2022-10-28","current":-11.542215,"twenty":-16.768347,"median":-10.953974,"eighty":-8.322526,"marketCap":1278358062},{"date":"2022-11-04","current":-10.914499,"twenty":-16.717916,"median":-10.967397,"eighty":-8.343685,"marketCap":1208835381},{"date":"2022-11-11","current":-11.344191,"twenty":-16.647312,"median":-10.962791,"eighty":-8.354397,"marketCap":1423695985},{"date":"2022-11-18","current":-10.049794,"twenty":-16.62714,"median":-10.967397,"eighty":-8.354465,"marketCap":1261249181},{"date":"2022-11-25","current":-10.525216,"twenty":-16.611581,"median":-10.949764,"eighty":-8.365585,"marketCap":1320914629},{"date":"2022-12-02","current":-11.278257,"twenty":-16.580652,"median":-10.937999,"eighty":-8.379929,"marketCap":1415421215},{"date":"2022-12-09","current":-9.435563,"twenty":-16.54284,"median":-10.900911,"eighty":-8.38732,"marketCap":1184163164},{"date":"2022-12-16","current":-9.373099,"twenty":-16.531101,"median":-10.878658,"eighty":-8.393763,"marketCap":1176323908},{"date":"2022-12-23","current":-8.609648,"twenty":-16.490733,"median":-10.784251,"eighty":-8.401054,"marketCap":1080510779},{"date":"2022-12-30","current":-8.550654,"twenty":-16.480889,"median":-10.755807,"eighty":-8.386195,"marketCap":1073107038},{"date":"2023-01-06","current":-8.026649,"twenty":-16.471483,"median":-10.69346,"eighty":-8.360025,"marketCap":1007344390},{"date":"2023-01-13","current":-8.210571,"twenty":-16.426351,"median":-10.672935,"eighty":-8.338773,"marketCap":1030426644},{"date":"2023-01-20","current":-8.391023,"twenty":-16.377843,"median":-10.653608,"eighty":-8.307919,"marketCap":1053073383},{"date":"2023-01-27","current":-9.418212,"twenty":-16.362213,"median":-10.622351,"eighty":-8.325121,"marketCap":1181985593},{"date":"2023-02-03","current":-8.953201,"twenty":-16.33033,"median":-10.598102,"eighty":-8.337136,"marketCap":1123626687},{"date":"2023-02-10","current":-8.016238,"twenty":-16.291538,"median":-10.582191,"eighty":-8.307919,"marketCap":1006037848},{"date":"2023-02-17","current":-8.311208,"twenty":-16.132459,"median":-10.5517,"eighty":-8.275092,"marketCap":1043056556},{"date":"2023-02-24","current":-8.030119,"twenty":-16.054745,"median":-10.525901,"eighty":-8.231392,"marketCap":1007779905},{"date":"2023-03-03","current":-8.387553,"twenty":-15.986664,"median":-10.497454,"eighty":-8.231392,"marketCap":1052637869},{"date":"2023-03-10","current":-6.435629,"twenty":-15.890044,"median":-10.456763,"eighty":-8.19669,"marketCap":934620687},{"date":"2023-03-17","current":-6.270613,"twenty":-15.797914,"median":-10.414026,"eighty":-8.099523,"marketCap":910656054},{"date":"2023-03-24","current":-5.790566,"twenty":-15.764767,"median":-10.407228,"eighty":-8.067817,"marketCap":840940758},{"date":"2023-03-31","current":-5.661554,"twenty":-15.730029,"median":-10.399775,"eighty":-8.033589,"marketCap":822204772},{"date":"2023-04-06","current":-5.208509,"twenty":-15.644351,"median":-10.35682,"eighty":-8.023608,"marketCap":756410961},{"date":"2023-04-14","current":-5.499418,"twenty":-15.574223,"median":-10.30432,"eighty":-7.994722,"marketCap":798658421},{"date":"2023-04-21","current":-5.892662,"twenty":-15.521886,"median":-10.270911,"eighty":-7.963641,"marketCap":855767729},{"date":"2023-04-28","current":-6.192849,"twenty":-15.371285,"median":-10.226889,"eighty":-7.840005,"marketCap":899362621},{"date":"2023-05-05","current":-8.07802,"twenty":-15.311904,"median":-10.209425,"eighty":-7.808348,"marketCap":1173138543},{"date":"2023-05-12","current":-6.709665,"twenty":-15.280047,"median":-10.16535,"eighty":-7.729148,"marketCap":1092923942},{"date":"2023-05-19","current":-6.50133,"twenty":-15.255016,"median":-10.150431,"eighty":-7.546255,"marketCap":1058988661},{"date":"2023-05-26","current":-6.166624,"twenty":-15.230664,"median":-10.123541,"eighty":-7.399027,"marketCap":1004469064},{"date":"2023-06-02","current":-6.482587,"twenty":-15.150093,"median":-10.101438,"eighty":-7.301546,"marketCap":1055935564},{"date":"2023-06-09","current":-6.578982,"twenty":-15.099664,"median":-10.081052,"eighty":-7.190357,"marketCap":1071637208},{"date":"2023-06-16","current":-7.449218,"twenty":-15.081916,"median":-10.06194,"eighty":-7.181675,"marketCap":1213388161},{"date":"2023-06-23","current":-7.130577,"twenty":-15.043354,"median":-10.049658,"eighty":-7.147018,"marketCap":1161485505},{"date":"2023-06-30","current":-6.889589,"twenty":-14.978471,"median":-10.010787,"eighty":-7.109449,"marketCap":1122231394},{"date":"2023-07-07","current":-6.694121,"twenty":-14.879324,"median":-10.003176,"eighty":-7.080055,"marketCap":1090391950},{"date":"2023-07-14","current":-6.71822,"twenty":-14.813575,"median":-9.929589,"eighty":-7.055067,"marketCap":1094317361},{"date":"2023-07-21","current":-6.734286,"twenty":-14.720843,"median":-9.757019,"eighty":-7.020794,"marketCap":1096934301},{"date":"2023-07-28","current":-5.612351,"twenty":-14.603223,"median":-9.723592,"eighty":-6.959208,"marketCap":914184610},{"date":"2023-08-04","current":-5.398139,"twenty":-14.56955,"median":-9.684017,"eighty":-6.913688,"marketCap":879292068},{"date":"2023-08-11","current":-4.03189,"twenty":-14.558043,"median":-9.636138,"eighty":-6.825667,"marketCap":694323632},{"date":"2023-08-18","current":-4.184036,"twenty":-14.524162,"median":-9.629385,"eighty":-6.795871,"marketCap":720524524},{"date":"2023-08-25","current":-4.754587,"twenty":-14.503242,"median":-9.590932,"eighty":-6.760289,"marketCap":818777868},{"date":"2023-09-01","current":-5.426568,"twenty":-14.469299,"median":-9.50261,"eighty":-6.734286,"marketCap":934498474},{"date":"2023-09-08","current":-5.464605,"twenty":-14.447925,"median":-9.46202,"eighty":-6.706556,"marketCap":941048697},{"date":"2023-09-15","current":-5.071559,"twenty":-14.422502,"median":-9.438069,"eighty":-6.644838,"marketCap":873363060},{"date":"2023-09-22","current":-4.949842,"twenty":-14.389111,"median":-9.414919,"eighty":-6.609239,"marketCap":852402346},{"date":"2023-09-29","current":-4.617655,"twenty":-14.346133,"median":-9.407047,"eighty":-6.577375,"marketCap":795197066},{"date":"2023-10-06","current":-4.749515,"twenty":-14.31098,"median":-9.378463,"eighty":-6.507756,"marketCap":817904505},{"date":"2023-10-13","current":-4.513688,"twenty":-14.290456,"median":-9.369034,"eighty":-6.480396,"marketCap":777293123},{"date":"2023-10-20","current":-4.009068,"twenty":-14.254834,"median":-9.345778,"eighty":-6.435381,"marketCap":690393498},{"date":"2023-10-27","current":-3.867064,"twenty":-14.245721,"median":-9.330985,"eighty":-6.382845,"marketCap":665939333},{"date":"2023-11-03","current":-4.062319,"twenty":-14.23073,"median":-9.300224,"eighty":-6.304458,"marketCap":699563811},{"date":"2023-11-10","current":-4.235537,"twenty":-14.186119,"median":-9.266506,"eighty":-6.270701,"marketCap":799127199},{"date":"2023-11-17","current":-5.26616,"twenty":-14.175985,"median":-9.233113,"eighty":-6.246101,"marketCap":993576892},{"date":"2023-11-24","current":-5.148354,"twenty":-14.166482,"median":-9.221106,"eighty":-6.167838,"marketCap":971350279},{"date":"2023-12-01","current":-5.206004,"twenty":-14.131341,"median":-9.105221,"eighty":-6.111798,"marketCap":982227132},{"date":"2023-12-08","current":-6.356488,"twenty":-14.04259,"median":-9.094269,"eighty":-6.096789,"marketCap":1199291289},{"date":"2023-12-15","current":-6.902905,"twenty":-14.028044,"median":-9.068239,"eighty":-6.096789,"marketCap":1302384941},{"date":"2023-12-22","current":-7.489427,"twenty":-14.025921,"median":-9.0546,"eighty":-6.100835,"marketCap":1413045100},{"date":"2023-12-29","current":-8.757716,"twenty":-14.008907,"median":-9.009394,"eighty":-6.107413,"marketCap":1652335870},{"date":"2024-01-05","current":-9.281575,"twenty":-13.987173,"median":-9.0546,"eighty":-6.120086,"marketCap":1751173361},{"date":"2024-01-12","current":-9.274056,"twenty":-13.943671,"median":-9.061419,"eighty":-6.154509,"marketCap":1749754642},{"date":"2024-01-19","current":-8.211299,"twenty":-13.935913,"median":-9.054023,"eighty":-6.159602,"marketCap":1549242218},{"date":"2024-01-26","current":-9.416751,"twenty":-13.905441,"median":-9.0546,"eighty":-6.166624,"marketCap":1776677287},{"date":"2024-02-02","current":-9.534775,"twenty":-13.893773,"median":-9.068239,"eighty":-6.167838,"marketCap":1798944976},{"date":"2024-02-09","current":-9.356484,"twenty":-13.878644,"median":-9.094269,"eighty":-6.192849,"marketCap":1765306552},{"date":"2024-02-16","current":-9.539797,"twenty":-13.835161,"median":-9.100679,"eighty":-6.225609,"marketCap":1799892537},{"date":"2024-02-23","current":-9.625175,"twenty":-13.830421,"median":-9.105273,"eighty":-6.230052,"marketCap":1816001078},{"date":"2024-03-01","current":-7.192485,"twenty":-13.817912,"median":-9.107687,"eighty":-6.241337,"marketCap":1735985333},{"date":"2024-03-08","current":-7.02362,"twenty":-13.807049,"median":-9.100679,"eighty":-6.252765,"marketCap":1695227829},{"date":"2024-03-15","current":-6.870463,"twenty":-13.801122,"median":-9.094269,"eighty":-6.255798,"marketCap":1658261720},{"date":"2024-03-22","current":-6.866535,"twenty":-13.794357,"median":-9.068239,"eighty":-6.258187,"marketCap":1657313871},{"date":"2024-03-28","current":-6.901879,"twenty":-13.75802,"median":-9.0546,"eighty":-6.261305,"marketCap":1665844512},{"date":"2024-04-05","current":-6.803702,"twenty":-13.722712,"median":-8.965343,"eighty":-6.267575,"marketCap":1642148288},{"date":"2024-04-12","current":-6.876353,"twenty":-13.699042,"median":-8.949082,"eighty":-6.270876,"marketCap":1659683493},{"date":"2024-04-19","current":-6.764431,"twenty":-13.676978,"median":-8.940031,"eighty":-6.285296,"marketCap":1632669799},{"date":"2024-04-26","current":-6.693743,"twenty":-13.636249,"median":-8.888993,"eighty":-6.295007,"marketCap":1615608518},{"date":"2024-05-03","current":-6.678035,"twenty":-13.606508,"median":-8.861134,"eighty":-6.300411,"marketCap":1611817122},{"date":"2024-05-10","current":-6.811556,"twenty":-13.591628,"median":-8.831645,"eighty":-6.305537,"marketCap":1644043986},{"date":"2024-05-17","current":-6.66535,"twenty":-13.56577,"median":-8.821685,"eighty":-6.320681,"marketCap":1807342945},{"date":"2024-05-24","current":-6.607374,"twenty":-13.544117,"median":-8.774994,"eighty":-6.333212,"marketCap":1791622362},{"date":"2024-05-31","current":-6.591913,"twenty":-13.536996,"median":-8.765808,"eighty":-6.33955,"marketCap":1787430207},{"date":"2024-06-07","current":-1.428017,"twenty":-13.534391,"median":-8.762512,"eighty":-6.320681,"marketCap":235088680},{"date":"2024-06-14","current":-1.458793,"twenty":-13.530648,"median":-8.74769,"eighty":-6.294936,"marketCap":240155247},{"date":"2024-06-21","current":-1.274136,"twenty":-13.527902,"median":-8.742788,"eighty":-6.264538,"marketCap":209755848},{"date":"2024-06-28","current":-1.236325,"twenty":-13.525827,"median":-8.73905,"eighty":-6.257641,"marketCap":203531210},{"date":"2024-07-05","current":-1.181807,"twenty":-13.520467,"median":-8.720695,"eighty":-6.23625,"marketCap":194556149},{"date":"2024-07-12","current":-1.1651,"twenty":-13.501419,"median":-8.701753,"eighty":-6.16711,"marketCap":191805728},{"date":"2024-07-15","current":-1.168617,"twenty":-13.494359,"median":-8.700162,"eighty":-6.163815,"marketCap":192384764},{"date":"2024-08-02","current":-1.28117,"twenty":-13.487298,"median":-8.699924,"eighty":-6.158329,"marketCap":210913921},{"date":"2024-08-09","current":-1.005943,"twenty":-13.450927,"median":-8.696095,"eighty":-6.09615,"marketCap":165604341},{"date":"2024-08-16","current":0.104301,"twenty":-13.431551,"median":-8.6648,"eighty":-6.071261,"marketCap":179428830},{"date":"2024-08-23","current":0.109307,"twenty":-13.403851,"median":-8.63741,"eighty":-5.995926,"marketCap":188041992},{"date":"2024-08-30","current":0.117049,"twenty":-13.39514,"median":-8.624442,"eighty":-5.904035,"marketCap":201359824},{"date":"2024-09-06","current":0.134972,"twenty":-13.390591,"median":-8.609648,"eighty":-5.798831,"marketCap":232193500},{"date":"2024-09-13","current":0.126894,"twenty":-13.3581,"median":-8.599787,"eighty":-5.718185,"marketCap":218296632},{"date":"2024-09-20","current":0.147174,"twenty":-13.320535,"median":-8.57594,"eighty":-5.693236,"marketCap":253183560},{"date":"2024-09-27","current":0.128998,"twenty":-13.305746,"median":-8.560338,"eighty":-5.649553,"marketCap":221915608},{"date":"2024-10-04","current":0.125211,"twenty":-13.276207,"median":-8.555407,"eighty":-5.607263,"marketCap":215401451},{"date":"2024-10-11","current":0.131102,"twenty":-13.252097,"median":-8.535683,"eighty":-5.58388,"marketCap":225534584},{"date":"2024-10-18","current":0.136066,"twenty":-13.240797,"median":-8.522393,"eighty":-5.549996,"marketCap":234075367},{"date":"2024-10-25","current":0.129334,"twenty":-13.231179,"median":-8.49513,"eighty":-5.503238,"marketCap":222494644},{"date":"2024-10-31","current":0.137076,"twenty":-13.224048,"median":-8.462226,"eighty":-5.484857,"marketCap":235812476},{"date":"2024-11-08","current":0.136824,"twenty":-13.217877,"median":-8.459506,"eighty":-5.448787,"marketCap":235378199},{"date":"2024-11-15","current":0.12003,"twenty":-13.207731,"median":-8.443665,"eighty":-5.380467,"marketCap":207439704},{"date":"2024-11-22","current":0.117098,"twenty":-13.192708,"median":-8.434596,"eighty":-5.31642,"marketCap":202373137},{"date":"2024-11-29","current":0.12782,"twenty":-13.171515,"median":-8.426987,"eighty":-5.264154,"marketCap":220902295},{"date":"2024-12-06","current":0.12648,"twenty":-13.08517,"median":-8.411844,"eighty":-5.216231,"marketCap":218586150},{"date":"2024-12-13","current":0.123548,"twenty":-13.067098,"median":-8.398818,"eighty":-5.199699,"marketCap":213519584},{"date":"2024-12-20","current":0.116261,"twenty":-13.024078,"median":-8.388445,"eighty":-5.177816,"marketCap":200925547},{"date":"2024-12-27","current":0.12514,"twenty":-13.01264,"median":-8.38282,"eighty":-5.148354,"marketCap":216270005},{"date":"2025-01-03","current":0.127736,"twenty":-12.995966,"median":-8.368365,"eighty":-5.142063,"marketCap":220757536},{"date":"2025-01-10","current":0.125475,"twenty":-12.979301,"median":-8.354397,"eighty":-5.097874,"marketCap":216849041},{"date":"2025-01-17","current":0.113413,"twenty":-12.968407,"median":-8.346533,"eighty":-5.070194,"marketCap":196003740},{"date":"2025-01-24","current":0.109644,"twenty":-12.940438,"median":-8.330294,"eighty":-5.039101,"marketCap":189489583},{"date":"2025-01-31","current":0.113497,"twenty":-12.895226,"median":-8.311208,"eighty":-4.971878,"marketCap":196148499},{"date":"2025-02-07","current":0.108471,"twenty":-12.866366,"median":-8.300882,"eighty":-4.937061,"marketCap":187462956},{"date":"2025-02-14","current":0.110063,"twenty":-12.829543,"median":-8.262624,"eighty":-4.888294,"marketCap":190213378},{"date":"2025-02-21","current":0.107215,"twenty":-12.818415,"median":-8.231392,"eighty":-4.86555,"marketCap":185291571},{"date":"2025-02-28","current":0.105539,"twenty":-12.791099,"median":-8.210935,"eighty":-4.812772,"marketCap":182396390},{"date":"2025-03-07","current":0.11157,"twenty":-12.69316,"median":-8.180554,"eighty":-4.789981,"marketCap":192819041},{"date":"2025-03-14","current":0.118522,"twenty":-12.662245,"median":-8.128541,"eighty":-4.744813,"marketCap":204834041},{"date":"2025-03-21","current":0.120949,"twenty":-12.654648,"median":-8.099523,"eighty":-4.702077,"marketCap":204110246},{"date":"2025-03-28","current":0.122836,"twenty":-12.635275,"median":-8.082172,"eighty":-4.65634,"marketCap":207294945},{"date":"2025-04-04","current":0.114344,"twenty":-12.608867,"median":-8.067817,"eighty":-4.615626,"marketCap":192963800},{"date":"2025-04-11","current":0.097102,"twenty":-12.580425,"median":-8.059594,"eighty":-4.551429,"marketCap":163867233},{"date":"2025-04-17","current":0.098389,"twenty":-12.561419,"median":-8.031854,"eighty":-4.48833,"marketCap":166038618},{"date":"2025-04-25","current":0.102764,"twenty":-12.551715,"median":-8.025451,"eighty":-4.412256,"marketCap":173421329},{"date":"2025-05-02","current":0.10568,"twenty":-12.478937,"median":-8.000315,"eighty":-4.235537,"marketCap":178343137},{"date":"2025-05-09","current":0.096588,"twenty":-12.439597,"median":-7.991946,"eighty":-4.089773,"marketCap":162998679},{"date":"2025-05-16","current":0.100989,"twenty":-12.434577,"median":-7.97539,"eighty":-4.044568,"marketCap":174000366},{"date":"2025-05-23","current":0.105357,"twenty":-12.381901,"median":-7.908838,"eighty":-3.993853,"marketCap":181527836},{"date":"2025-05-30","current":0.115524,"twenty":-12.32239,"median":-7.842802,"eighty":-3.849968,"marketCap":199043680},{"date":"2025-06-06","current":0.108298,"twenty":-12.28145,"median":-7.820969,"eighty":-3.684995,"marketCap":186594402},{"date":"2025-06-13","current":0.120397,"twenty":-12.27012,"median":-7.741529,"eighty":-1.480952,"marketCap":207439704},{"date":"2025-06-20","current":0.12779,"twenty":-12.256868,"median":-7.679625,"eighty":-1.456331,"marketCap":220178499},{"date":"2025-06-27","current":0.124261,"twenty":-12.215704,"median":-7.603614,"eighty":-1.340788,"marketCap":214098620},{"date":"2025-07-03","current":0.1372,"twenty":-12.181568,"median":-7.503213,"eighty":-1.260418,"marketCap":236391512},{"date":"2025-07-11","current":0.176268,"twenty":-12.147999,"median":-7.450386,"eighty":-1.219442,"marketCap":303704465},{"date":"2025-07-18","current":0.198448,"twenty":-12.097216,"median":-7.41608,"eighty":-1.173893,"marketCap":341920852},{"date":"2025-07-25","current":0.193827,"twenty":-12.055911,"median":-7.368888,"eighty":-1.136258,"marketCap":333959105},{"date":"2025-08-01","current":0.184165,"twenty":-12.0097,"median":-7.300695,"eighty":-1.006646,"marketCap":317311815},{"date":"2025-08-08","current":0.179293,"twenty":-11.932996,"median":-7.27517,"eighty":0.093431,"marketCap":308915791},{"date":"2025-08-15","current":-2.118471,"twenty":-11.899726,"median":-7.210926,"eighty":0.095163,"marketCap":346780978},{"date":"2025-08-22","current":-2.137939,"twenty":-11.899726,"median":-7.188912,"eighty":0.095163,"marketCap":349967771},{"date":"2025-08-29","current":-2.467125,"twenty":-11.899726,"median":-7.117001,"eighty":0.095163,"marketCap":403853537},{"date":"2025-09-05","current":-2.452966,"twenty":-11.910821,"median":-7.080055,"eighty":0.095189,"marketCap":401535870},{"date":"2025-09-12","current":-2.517565,"twenty":-11.899726,"median":-7.052928,"eighty":0.095163,"marketCap":412110227},{"date":"2025-09-19","current":-2.358281,"twenty":-11.899726,"median":-7.022207,"eighty":0.095163,"marketCap":386036469},{"date":"2025-09-26","current":-2.817991,"twenty":-11.899726,"median":-6.994363,"eighty":0.095163,"marketCap":461288231},{"date":"2025-10-03","current":-3.102932,"twenty":-11.899726,"median":-6.957161,"eighty":0.095163,"marketCap":507931287},{"date":"2025-10-10","current":-3.09718,"twenty":-11.899726,"median":-6.916619,"eighty":0.095163,"marketCap":506989735},{"date":"2025-10-17","current":-3.238323,"twenty":-11.899726,"median":-6.888862,"eighty":0.095163,"marketCap":530093981},{"date":"2025-10-24","current":-2.5096,"twenty":-11.899726,"median":-6.871444,"eighty":0.095163,"marketCap":410806539},{"date":"2025-10-31","current":-6.947417,"twenty":-11.899726,"median":-6.866535,"eighty":0.095163,"marketCap":1137250402},{"date":"2025-11-07","current":-7.166874,"twenty":-11.899726,"median":-6.866535,"eighty":0.095163,"marketCap":1173174246},{"date":"2025-11-14","current":-6.603187,"twenty":-11.899726,"median":-6.865553,"eighty":0.095163,"marketCap":1080902115},{"date":"2025-11-21","current":-7.487278,"twenty":-11.861937,"median":-6.865553,"eighty":0.095163,"marketCap":1161172041},{"date":"2025-11-28","current":-7.88865,"twenty":-11.742377,"median":-6.865553,"eighty":0.095163,"marketCap":1223419240},{"date":"2025-12-05","current":-8.197182,"twenty":-11.617777,"median":-6.865553,"eighty":0.095163,"marketCap":1271268138},{"date":"2025-12-12","current":-7.709533,"twenty":-11.403957,"median":-6.865553,"eighty":0.095163,"marketCap":1195640700},{"date":"2025-12-19","current":-8.001185,"twenty":-11.337354,"median":-6.865553,"eighty":0.095163,"marketCap":1240871726},{"date":"2025-12-26","current":-7.536043,"twenty":-11.289254,"median":-6.865553,"eighty":0.095163,"marketCap":1168734785},{"date":"2026-01-02","current":-7.408504,"twenty":-11.181733,"median":-6.865553,"eighty":0.095163,"marketCap":1148955302},{"date":"2026-01-09","current":-7.052146,"twenty":-11.074324,"median":-6.865553,"eighty":0.095163,"marketCap":1093689097},{"date":"2026-01-16","current":-6.733299,"twenty":-10.974222,"median":-6.860645,"eighty":0.095163,"marketCap":1044240388},{"date":"2026-01-23","current":-7.454456,"twenty":-10.939172,"median":-6.859408,"eighty":0.095163,"marketCap":1156081733},{"date":"2026-01-30","current":-6.804571,"twenty":-10.880889,"median":-6.848864,"eighty":0.095163,"marketCap":1055293629},{"date":"2026-02-06","current":-7.645764,"twenty":-10.722571,"median":-6.848864,"eighty":0.095163,"marketCap":1185750959},{"date":"2026-02-13","current":-7.700156,"twenty":-10.655341,"median":-6.848864,"eighty":0.095163,"marketCap":1194186327},{"date":"2026-02-20","current":-7.603564,"twenty":-10.601716,"median":-6.848864,"eighty":0.095163,"marketCap":1179206277},{"date":"2026-02-27","current":-7.242516,"twenty":-10.568541,"median":-6.848864,"eighty":0.095163,"marketCap":1123212885},{"date":"2026-03-06","current":-6.626391,"twenty":-10.505783,"median":-6.845284,"eighty":0.095163,"marketCap":1027660527},{"date":"2026-03-13","current":-6.498853,"twenty":-10.428161,"median":-6.829185,"eighty":0.095163,"marketCap":1007881043},{"date":"2026-03-20","current":-6.765617,"twenty":-10.386411,"median":-6.812729,"eighty":0.095163,"marketCap":947558425},{"date":"2026-03-27","current":-6.861568,"twenty":-10.343704,"median":-6.806916,"eighty":0.095163,"marketCap":960996898},{"date":"2026-04-02","current":-6.99298,"twenty":-10.343704,"median":-6.799786,"eighty":0.095163,"marketCap":979401763},{"date":"2026-04-10","current":-7.900346,"twenty":-10.298288,"median":-6.792174,"eighty":0.095163,"marketCap":1106482977},{"date":"2026-04-17","current":-8.667957,"twenty":-10.251785,"median":-6.792174,"eighty":0.095163,"marketCap":1213990761},{"date":"2026-04-24","current":-12.508099,"twenty":-10.281908,"median":-6.792174,"eighty":0.095163,"marketCap":1751821827},{"date":"2026-05-01","current":-13.476187,"twenty":-10.362548,"median":-6.792174,"eighty":0.095163,"marketCap":1887407424},{"date":"2026-05-08","current":-12.987035,"twenty":-10.481137,"median":-6.792174,"eighty":0.095163,"marketCap":1818899252},{"date":"2026-05-15","current":-13.09064,"twenty":-10.541397,"median":-6.792174,"eighty":0.095163,"marketCap":1704204965},{"date":"2026-05-22","current":-12.460675,"twenty":-10.629123,"median":-6.792174,"eighty":0.095163,"marketCap":1622193036},{"date":"2026-05-29","current":-11.718016,"twenty":-10.669392,"median":-6.788501,"eighty":0.095189,"marketCap":1525509920},{"date":"2026-06-05","current":-10.28341,"twenty":-10.673287,"median":-6.792174,"eighty":0.095163,"marketCap":1338745722},{"date":"2026-06-12","current":-10.541481,"twenty":-10.587946,"median":-6.792174,"eighty":0.095163,"marketCap":1372342738},{"date":"2026-06-18","current":-10.61586,"twenty":-10.547355,"median":-6.792174,"eighty":0.095163,"marketCap":1382025721},{"date":"2026-06-26","current":-10.740951,"twenty":-10.52306,"median":-6.788501,"eighty":0.095189,"marketCap":1398310737},{"date":"2026-07-02","current":-10.699254,"twenty":-10.52306,"median":-6.788501,"eighty":0.095189,"marketCap":1392882398},{"date":"2026-07-10","current":-11.703366,"twenty":-10.52306,"median":-6.788501,"eighty":0.095189,"marketCap":1523602666},{"date":"2026-07-17","current":-10.037735,"twenty":-10.494482,"median":-6.788501,"eighty":0.095189,"marketCap":1306762537},{"date":"2026-07-24","current":-9.579067,"twenty":-10.450596,"median":-6.788501,"eighty":0.095189,"marketCap":1247050810},{"date":"2026-07-31","current":-9.548639,"twenty":-10.386526,"median":-6.78817,"eighty":0.095215,"marketCap":1243089589},{"date":"2026-08-07","current":-9.668096,"twenty":-10.28924,"median":-6.78817,"eighty":0.095215,"marketCap":1258641046},{"date":"2026-08-14","current":-10.967164,"twenty":-10.28341,"median":-6.78817,"eighty":0.095215,"marketCap":1427760196},{"date":"2026-08-21","current":-10.560468,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1459255989},{"date":"2026-08-28","current":-13.199786,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1823959603},{"date":"2026-09-04","current":-13.021914,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1799381111},{"date":"2026-09-11","current":-11.867346,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1639841677},{"date":"2026-09-18","current":-11.154794,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1541380531}],"updateTime":1789812564372},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INBX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668391912","title":"Top Insider Makes Bold Move at Inhibrx Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2668391912","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668391912?lang=en_us&edition=fundamental","pubTime":"2026-09-18 10:03","pubTimestamp":1789696982,"startTime":"0","endTime":"0","summary":"New insider activity at Inhibrx Biosciences Inc ( ($INBX) ) has taken place on September 17, 2026. Director Jon Faiz Kayyem has significantly incre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-insider-makes-bold-move-at-inhibrx-biosciences-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-insider-makes-bold-move-at-inhibrx-biosciences-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668977709","title":"Inhibrx Biosciences Director Jon Faiz Kayyem Acquires $500,000 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2668977709","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668977709?lang=en_us&edition=fundamental","pubTime":"2026-09-18 05:47","pubTimestamp":1789681642,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences director Jon Faiz Kayyem acquires $500,000 in common sharesInhibrx Biosciences director Jon Faiz Kayyem reported an indirect purchase of 5,000 common shares at USD 100 each.Family ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL8FPg3b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Inhibrx Biosciences Director Jon Faiz Kayyem Acquires $500,000 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666519787","title":"Inhibrx Biosciences Director Kimberly Manhard Sells Common Shares Worth $115,467.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2666519787","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666519787?lang=en_us&edition=fundamental","pubTime":"2026-09-11 07:06","pubTimestamp":1789081597,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences Director Kimberly Manhard sells common shares worth $115,467.50Inhibrx Biosciences director Kimberly Manhard sold 1,000 shares on Sept. 8-9.Sales priced at $115.14 to $115.8 per sh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL1772mK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Inhibrx Biosciences Director Kimberly Manhard Sells Common Shares Worth $115,467.50","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377221","title":"Inhibrx Biosciences reports strong Phase 2 INBRX-106 data","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377221","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377221?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:39","pubTimestamp":1788899956,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences Inc ( ($INBX) ) has provided an announcement. On September 8, 2026, Inhibrx Biosciences reported primary endpoint data from the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-reports-strong-phase-2-inbrx-106-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-reports-strong-phase-2-inbrx-106-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372032","title":"Inhibrx CEO Mark Lappe Reports Acquisition of 25,000 Common Shares Worth $2.59 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372032","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372032?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897932,"startTime":"0","endTime":"0","summary":"Inhibrx CEO Mark Lappe reports acquisition of 25,000 common shares worth $2.59 millionInhibrx Biosciences CEO Mark Lappe reported open-market purchases totaling 25,000 common shares at weighted-averag","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL2Cmjwm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Inhibrx CEO Mark Lappe Reports Acquisition of 25,000 Common Shares Worth $2.59 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665937657","title":"Inhibrx Biosciences Shares Fall 22% After Co Releases Data from Mid-Stage Study of Its Experimental Combination Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2665937657","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665937657?lang=en_us&edition=fundamental","pubTime":"2026-09-08 22:17","pubTimestamp":1788877020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N45015Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375756","title":"Analysts Offer Insights on NA Companies: First Horizon (FHN) and Inhibrx Biosciences Inc (INBX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375756","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375756?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:40","pubTimestamp":1788874808,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on First Horizon (FHN) and Inhibrx Biosciences Inc (INBX) with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-first-horizon-fhn-and-inhibrx-biosciences-inc-inbx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-first-horizon-fhn-and-inhibrx-biosciences-inc-inbx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4141","FHN","INBX","BK4589","NA","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665780933","title":"Inhibrx Biosciences Says Cancer Combination Therapy Shows Improved Response in Phase 2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665780933","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665780933?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:50","pubTimestamp":1788871810,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences'  experimental cancer drug, INBRX-106, nearly doubled the response rate when combined with pembrolizumab in a phase 2 trial for head and neck cancer, the drugmaker said Tuesday.The combination produced a confirmed objective response rate of 48.3%, compared with 26.5% for pembrolizumab alone, Inhibrx said.Complete responses occurred in 13.8% of patients receiving the combination, while none were reported in the control group, with median progression-free survival of 9.6 months versus 4.9 months, respectively, the company said.The benefit was stronger in patients with HPV-positive disease, with an 80% confirmed objective response rate for the combination versus 33.3% for pembrolizumab alone, the company said.Inhibrx said it plans to add about 50 HPV-positive oropharyngeal cancer patients to the phase 2 trial and then discuss a potential phase 3 confirmatory study with the US Food and Drug Administration.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665270773","title":"Inhibrx Biosciences Reports Positive Study Results for Squamous Cell Carcinoma Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2665270773","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665270773?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:57","pubTimestamp":1788868620,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences reported positive results from a Phase 2 study of a potential treatment for metastatic or unresectable recurrent head and neck squamous cell carcinoma.The clinical-stage biopharmaceutical company said Tuesday its INBRX-106 drug in combination with pembrolizumab demonstrated a confirmed objective response rate of 48% compared with about 27% for pembrolizumab alone. About 14% of patients in the combination arm achieved a complete response, compared with no complete responses in the control arm, the company said.Additionally, median progression-free survival stood at 9.6 months for the drug combination versus 4.9 months for pembrolizumab alone as of the data cutoff.The drug combination showed particular efficacy in patients with HPV+ disease, which has prompted the company to expand the study by about 50 additional HPV+ oropharyngeal squamous cell carcinoma patients as it eyes a potential accelerated regulatory pathway.The results \"give us a strong rationale to expand ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Inhibrx Biosciences Reports Positive Study Results for Squamous Cell Carcinoma Treatment","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327604","title":"Inhibrx Says Phase 2 Trial Shows INBRX-106 Plus Pembrolizumab Lifts Response Rate to 48.3% in HNSCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327604","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327604?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:31","pubTimestamp":1788867093,"startTime":"0","endTime":"0","summary":"Inhibrx says Phase 2 trial shows INBRX-106 plus pembrolizumab lifts response rate to 48.3% in HNSCCInhibrx reported primary endpoint results from a randomized Phase 2 HexAgon study of INBRX-106 with p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL2090dK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665981327","title":"Inhibrx Biosciences: Currently Conducting Phase 1/2 Study of Inbrx-106 in Perioperative Setting of Nsclc, with Initial Results Targeted by Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2665981327","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665981327?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA5886QW:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665648327","title":"Inhibrx Biosciences Inc: Evaluating Potential of Inbrx-106 in Other Highly Immunogenic Tumor Types","url":"https://stock-news.laohu8.com/highlight/detail?id=2665648327","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665648327?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA5886QW:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665432763","title":"Inhibrx Biosciences - to Expand Phase 2 Study by 50 Hpv+ Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2665432763","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665432763?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA5886QW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665332768","title":"Inhibrx Biosciences - Inbrx-106 Plus Pembrolizumab Achieves 48.3% Corr and 72.4% Six-Month Pfs Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2665332768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665332768?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA5886QW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327647","title":"Inhibrx Biosciences Inc: Also Plans to Explore Potential of Inbrx-106 in Combination with Therapeutic Cancer Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327647?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA5886QW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665275703","title":"Inhibrx's Inbrx-106 Nearly Doubles Response Rate and Achieves Interim Median Pfs of 9.6 Months in Phase 2 Hnscc Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665275703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665275703?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA5886QW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665632734","title":"NASDAQ Trade Halt Halt News Pending at 07:25 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2665632734","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665632734?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:25","pubTimestamp":1788866700,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTHALT NEWS PENDING AT 07:25 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nAQN2MICOY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665535914","title":"Inhibrx Schedules Sept. 8 Webcast to Release Phase 2 INBRX-106 First-Line HNSCC Study Endpoint Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665535914","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665535914?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:00","pubTimestamp":1788552022,"startTime":"0","endTime":"0","summary":"Inhibrx schedules Sept. 8 webcast to release Phase 2 INBRX-106 first-line HNSCC study endpoint resultsInhibrx scheduled a Sept. 8 webcast to present primary endpoint results from the Phase 2 portion o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL8WKz46:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278582","title":"Inhibrx Biosciences Price Target Announced at $245.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278582","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278582?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/INBX/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661220881","title":"Inhibrx Biosciences, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $245","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220881","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661220881?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:08","pubTimestamp":1787566121,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nAZN4TFZ0I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":95,"code":"91000000","status":"200"}]}}